Treatment of toxic epidermal necrolysis: the uncertainty persists but the fog is dispersing.
Wolff
Klaus
K
Tappeiner
Gerhard
G
D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D013262:Stevens-Johnson Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome
D016756:Immunoglobulins, Intravenous